Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warmed vs Room Temperature Bupivacaine for Infraclavicular Brachial Plexus Block
NCT03346993Phase 1Completed
- Sponsor
- Erzurum Palandöken State Hospital
- Start
- Jul 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bupivacaine (2 arms), sponsored by Erzurum Palandöken State Hospital. Primary endpoint: Sensory Block Onset Time at 30 minutes. Started Jul 2016; status: completed.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on NCT03346993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03346993.